Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 145,824 | 164,838 | 52,145 | 0 | 0 |
| Marketable Securities | 16,935 | 17,609 | 17,014 | 0 | 0 |
| TOTAL | $164,473 | $184,378 | $70,658 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 6,551 | 4,418 | 2,429 | N/A | N/A |
| Other Non-Current Assets | 446 | 446 | 3,106 | 0 | 0 |
| TOTAL | $6,997 | $4,864 | $5,535 | $N/A | $N/A |
| Total Assets | $171,470 | $189,242 | $76,193 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,741 | 5,835 | 5,066 | 0 | 0 |
| Accrued Expenses | 4,938 | 4,092 | 5,972 | 0 | 0 |
| Other current liabilities | N/A | N/A | 233 | 0 | 0 |
| TOTAL | $8,679 | $9,927 | $11,271 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 499 | 365 | 124,179 | 0 | 0 |
| TOTAL | $499 | $365 | $124,179 | $N/A | $N/A |
| Total Liabilities | $9,178 | $10,292 | $135,450 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,363 | 2,365 | N/A | N/A | N/A |
| Common Shares | 35 | 35 | 65,014 | 0 | 0 |
| Retained earnings | -158,115 | -140,135 | -124,258 | 0 | 0 |
| Other shareholders' equity | -10 | -23 | -13 | 0 | 0 |
| TOTAL | $162,292 | $178,950 | $-59,257 | $0 | $0 |
| Total Liabilities And Equity | $171,470 | $189,242 | $76,193 | $0 | $0 |